Mechanisms of dexamethasone-mediated inhibition of toll-like receptor signaling induced by Neisseria meningitidis and Streptococcus pneumoniae

Infection and Immunity

Volumn 76, Issue 1, 2008, Pages 189-197

  Mogensen, Trine H ^a   Berg, Randi S ^a,b   Paludan, Søren R ^b   Østergaard, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; DEXAMETHASONE; DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INFLAMMATION; INHIBITION KINETICS; MOLECULAR MECHANICS; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANIMALS; CELLS, CULTURED; DEXAMETHASONE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGES; MICE; NEISSERIA MENINGITIDIS; NEUTROPHILS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTORS;

EID: 37749027492     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00856-07     Document Type: Article

References (48)

1. Adcock, I. M., and G. Caramori. 2001. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol. Cell Biol. 79:376-384.
2. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511.
3. Albiger, B., S. Dahlberg, A. Sandgren, F. Wartha, K. Beiter, H. Katsuragi, S. Akira, S. Normark, and B. Henriques-Normark. 2007. Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell. Microbiol. 9:633-644.
4. Almawi, W. Y., and O. K. Melemedjian. 2002. Negative regulation of nuclear factor-κB activation and function by glucocorticoids. J. Mol. Endocrinol. 28:69-78.
5. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.
6. Beato, M., P. Herrlich, and G. Schutz. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
7. Bhattacharyya, S., D. E. Brown, J. A. Brewer, S. K. Vogt, and L. J. Muglia. 2007. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109:4313-4319.
8. Caelles, C., J. M. Gonzalez-Sancho, and A. Munoz. 1997. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11:3351-3364.
9. Chaudhuri, A., and P. O. Behan. 2004. Fatigue in neurological disorders. Lancet 363:978-988.
10. Dean, J. L., G. Sully, A. R. Clark, and J. Saklatvala. 2004. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal. 16:1113-1121.
11. de Gans, J., and D. van de Beek. 2002. Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 347:1549-1556.
12. Dunne, A., and L. A. O'Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2003:re3.
13. Fowler, M. I., R. O. Weller, J. E. Heckels, and M. Christodoulides. 2004. Different meningitis-causing bacteria induce distinct inflammatory responses on interaction with cells of the human meninges. Cell. Microbiol. 6:555-567.
14. Garcia-Bustos, J., and A. Tomasz. 1989. Mechanism of pneumococcal cell wall degradation in vitro and in vivo. J. Bacteriol. 171:114-119.
15. Gonzalez, M. V., J. M. Gonzalez-Sancho, C. Caelles, A. Munoz, and B. Jimenez. 1999. Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells. FEBS Lett. 459:272-276.
16. Han, J., T. Brown, and B. Beutler. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171:465-475.
17. Imasato, A., C. Desbois-Mouthon, J. Han, H. Kai, A. C. Cato, S. Akira, and J. D. Li. 2002. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of Toll-like receptor 2. J. Biol. Chem. 277:47444-47450.
18. Ingalls, R. R., E. Lien, and D. T. Golenbock. 2000. Differential roles of TLR2 and TLR4 in the host response to gram-negative bacteria: lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidis. J. Endotoxin Res. 6:411-415.
19. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-995.
20. Jiang, Z., M. Zamanian-Daryoush, H. Nie, A. M. Silva, B. R. Williams, and X. Li. 2003. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFκB and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. J. Biol. Chem. 278:16713-16719.
21. Katsuyama, K., M. Shichiri, H. Kato, T. Imai, F. Marumo, and Y. Hirata. 1999. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Endocrinology 140:2183-2190.
22. Khabar, K. S. 2005. The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. J. Interferon Cytokine Res. 25:1-10.
23. Koedel, U., T. Rupprecht, B. Angele, J. Heesemann, H. Wagner, H. W. Pfister, and C. J. Kirschning. 2004. MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain 127:1437-1445.
24. Korhonen, R., A. Lahti, M. Hamalainen, H. Kankaanranta, and E. Moilanen. 2002. Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages. Mol. Pharmacol. 62:698-704.
25. Lasa, M., M. Brook, J. Saklatvala, and A. R. Clark. 2001. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 21:771-780.
26. Liu, Z. G. 2005. Molecular mechanism of TNF signaling and beyond. Cell Res. 15:24-27.
27. Ma, W., K. Gee, W. Lim, K. Chambers, J. B. Angel, M. Kozlowski, and A. Kumar. 2004. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-κB transcription factors. J. Immunol. 172:318-330.
28. Massari, P., P. Henneke, Y. Ho, E. Latz, D. T. Golenbock, and L. M. Wetzler. 2002. Cutting edge: immune stimulation by neisserial porins is Toll-like receptor 2 and MyD88 dependent. J. Immunol. 168:1533-1537.
29. McIntyre, P. B., C. S. Berkey, S. M. King, U. B. Schaad, T. Kilpi, G. Y. Kanra, and C. M. Perez. 1997. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278:925-931.
30. Mogensen, T. H., S. R. Paludan, M. Kilian, and L. Ostergaard. 2006. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J. Leukoc. Biol. 80:267-277.
31. Moore, L. J., A. C. Pridmore, M. E. Lee, and R. C. Read. 2005. Induction of pro-inflammatory cytokine release by human macrophages during exposure of Streptococcus pneumoniae to penicillin is influenced by minimum inhibitory concentration ratio. Int. J. Antimicrob. Agents 26:188-196.
32. Moynagh, P. N. 2003. Toll-like receptor signalling pathways as key targets for mediating the anti-inflammatory and immunosuppressive effects of glucocorticoids. J. Endocrinol. 179:139-144.
33. Odio, C. M., I. Faingezicht, M. Paris, M. Nassar, A. Baltodano, J. Rogers, X. Saez-Llorens, K. D. Olsen, and G. H. McCracken, Jr. 1991. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N. Engl. J. Med. 324:1525-1531.
34. Ogawa, S., J. Lozach, C. Benner, G. Pascual, R. K. Tangirala, S. Westin, A. Hoffmann, S. Subramaniam, M. David, M. G. Rosenfeld, and C. K. Glass. 2005. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122:707-721.
35. O'Neill, L. A. 2006. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18:3-9.
36. Paludan, S. R., S. Ellermann-Eriksen, V. Kruys, and S. C. Mogensen. 2001. Expression of TNF-α by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF-κB and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the 3′ untranslated region. J. Immunol. 167:2202-2208.
37. Quan, N., L. He, W. Lai, T. Shen, and M. Herkenham. 2000. Induction of IκBα mRNA expression in the brain by glucocorticoids: a negative feedback mechanism for immune-to-brain signaling. J. Neurosci. 20:6473-6477.
38. Raj, N. B., and P. M. Pitha. 1983. Two levels of regulation of beta-interferon gene expression in human cells. Proc. Natl. Acad. Sci. USA 80:3923-3927.
39. Reddy, K. V., G. Bhattacharjee, G. Schabbauer, A. Hollis, K. Kempf, M. Tencati, M. O'Connell, M. Guha, and N. Mackman. 2004. Dexamethasone enhances LPS induction of tissue factor expression in human monocytic cells by increasing tissue factor mRNA stability. J. Leukoc. Biol. 76:145-151.
40. Saez-Llorens, X., and G. H. McCracken, Jr. 2003. Bacterial meningitis in children. Lancet 361:2139-2148.
41. Sakai, A., J. Han, A. C. Cato, S. Akira, and J. D. Li. 2004. Glucocorticoids synergize with IL-1β to induce TLR2 expression via MAP kinase phosphatase-1-dependent dual inhibition of MAPK JNK and p38 in epithelial cells. BMC Mol. Biol. 5:2.
42. Sato, S., M. Sugiyama, M. Yamamoto, Y. Watanabe, T. Kawai, K. Takeda, and S. Akira. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171:4304-4310.
43. Swantek, J. L., M. H. Cobb, and T. D. Geppert. 1997. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor α(TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol. Cell. Biol. 17:6274-6282.
44. van de Beek, D., J. de Gans, P. McIntyre, and K. Prasad. 2004. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect. Dis. 4:139-143.
45. Vital, A. L., M. Goncalo, M. T. Cruz, A. Figueiredo, C. B. Duarte, and M. C. Lopes. 2003. Dexamethasone prevents granulocyte-macrophage colony-stimulating factor-induced nuclear factor-κB activation, inducible nitric oxide synthase expression and nitric oxide production in a skin dendritic cell line. Mediators Inflamm. 12:71-78.
46. Willeaume, V., V. Kruys, T. Mijatovic, and G. Huez. 1995. Tumor necrosis factor-α production induced by viruses and by lipopolysaccharides in macrophages: similarities and differences. J. Inflamm. 46:1-12.
47. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1-5.
48. Zughaier, S. M., Y. L. Tzeng, S. M. Zimmer, A. Datta, R. W. Carlson, and D. S. Stephens. 2004. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect. Immun. 72:371-380.